我国卫生区域划分研究

目的:我国不同地区卫生资源发展不平衡,制定区域卫生规划要综合考虑不同地区的经济、社会、人口、健康等方面的状况。方法:利用统计年鉴数据,考虑经济、社会、人口、健康等因素,分别通过主成分分析和因子分析方法计算不同地区的综合得分,然后对综合得分进行聚类分析。结果:主成分分析综合得分和因子分析综合得分的聚类分析将全国以省(自治区、直辖市)为单元划分为6类地区,两种分析方法的分类结果类似。结论:将全国卫生区域分为六类,第一类地区:上海市、北京市;第二类地区:天津市;第三类地区:江苏省、浙江省、广东省;第四类地区:辽宁省、山东省、福建省、内蒙古自治区、吉林省、重庆市、陕西省、湖北省、黑龙江省、山西省、河南省、湖南省、河北省、海南省、四川省、江西省、安徽省;第五类地区为:广西壮族自治区、宁夏回族自治区、新疆维吾尔自治区、甘肃省、青海省、贵州省、云南省;第六类地区为:西藏自治区。分类结果基本符合中国31个省(自治区、直辖市)的卫生发展实际。     

2012年我国农村妇女宫颈癌检查状况分析

目的分析我国农村妇女宫颈癌检查项目工作现状。方法利用全国重大公共卫生项目"两癌"检查项目信息直报系统,对2012年宫颈癌检查上报数据进行分析。结果 2012年全国对35~64岁的农村妇女进行宫颈癌检查10 621 482例,任务完成率106.2%,其中东、中、西部任务完成率分别为97.2%、112.9%及102.4%。检查人群中,81.76%的妇女既往从未接受过宫颈癌检查。运用宫颈细胞学检查及醋酸/碘染色(VIA/VILI)方法进行初筛的比例分别为77.17%和18.55%。在宫颈细胞学检查中,运用TBS描述性报告阅片的比例为65.49%,巴氏分级报告的比例为34.51%。宫颈细胞学检查结果异常或可疑病例检出率为3.93%,醋酸/碘染色检查结果异常或可疑病例检出率为11.05%。宫颈癌初筛检查的可疑/异常人群中,分别有17.01%、9.66%的妇女未接受阴道镜及病理学检查。宫颈癌前病变(CINII、III)及宫颈癌检出率124.87/10万、早诊率89.60%。结论多数地区应用宫颈细胞学检查方法作为宫颈癌初筛检查手段,但应用TBS报告结果的比例和异常结果检出率尚需进一步提高,亟需加强参与宫颈癌检查的相关人员技术培训及可疑/阳性人群的管理,进一步提高宫颈癌检查效果。     

加强能力建设预防医院感染

<正>医院感染直接影响医疗质量和患者安全,是现代医院管理的难题和面临的重要挑战。20世纪80年代中期我国开始重视医院感染管理工作,并加快推进医院感染管理事业的发展。近30年来,医院感染管理方面发生了翻天覆地的变化,取得了丰硕的成果,这在医院感染管理法律、法规、标准等建立     

大数据理解误区解读

大数据时代,面对众说纷纭的大数据热,本文详细地解读了大数据可以替代抽样调查、大数据不重视因果关系、大数据放松了数据质量、大数据可以完全取代数据科学家、大数据时代先收集数据后进行数据分析这5个误区。在此基础上,提出了在大数据发展的方兴未艾阶段如何更好地利用大数据的一些建议。     

In utero exposure to the endocrine disruptor di(2-ethylhexyl) phthalate targets ovarian theca cells and steroidogenesis in the adult female rat

Di-2-ethylhexyl phthalate (DEHP) is an endocrine disruptor used in industry as an additive to polyvinyl chloride-based products. Pregnant dams were gavaged with oil, 1, 20, 50, or 300 mg of DEHP/kg/day from gestational day 14 until birth in order to characterize the effects of DEHP in the adult female offspring. In utero exposure to DEHP resulted in reduced estrogen levels at proestrus. Theca cell layer thickness was decreased starting at 50 mg DEHP/kg/day dose. Follicle-stimulating hormone levels were significantly increased at proestrus and estrus. F1 reproduction using a known breeder was not affected. F3 generation showed a decreased pregnancy rate and weight, and increased litter size in the animals exposed to 20 mg DEHP/kg/day. The data presented herein suggest that in utero exposure to DEHP targets the theca cell layer and decreases the estrus cycle steroid surge, but despite these effects, does not cause infertility.     

Blood donation in China: sustaining efforts and challenges in achieving safety and availability

China has entered a new phase in blood safety and availability through persistent efforts in the past decades. Based on national data from 2008 to 2012, we present a comprehensive review on the blood services ranging from policy and organization, supply, donors, screening and processing, and clinical use to government response in contemporary China. Current evidence suggests that the Chinese blood industries, after continual efforts in reforms on the legal framework and national management system, have been in a relatively steady but bottleneck stage. Although the blood industries have had an impressive track record on management and resolving problems, such as low availability, limited donors, deficient laboratory tests, shortage of blood products, and unnecessary clinical usage of blood still exist nationwide. While medical technology and services have seen a rapid increase in progress in recent years, they have not coordinated with the development of the national health care system. This article presents an analysis with detailed data, rich contents, and recent response from the Chinese government, allowing readers to appreciate how China, a country with more than 19.13% of the world's population, has long endeavored to improve safety and availability of blood. Meantime, the article sincerely welcomes the guidance on policymaking and technical assistance from the international community. Data in this article do not include those of Hong Kong, Macao, or Taiwan.     

The reference values for semen parameters of 1213 fertile men in Guangdong Province in China

Semen samples were collected from 1213 fertile men whose partners had a time-to-pregnancy (TTP) ≤12 months in Guangdong Province in Southern China, and semen parameters including semen volume, sperm concentration, total counts, motility, and morphology were evaluated according to the World Health Organization (WHO) 2010 guideline. All semen parameters analyzed were normal in ~62.2% of the total samples, whereas ~37.8% showed at least one of the semen parameters below normal threshold values. The fifth centiles (with 95% confidence intervals) were 1.3 (1.2–1.5) ml for semen volume, 20 × 10⁶ (18×10⁶–20×10⁶) ml⁻¹ for sperm concentration, 40 × 10⁶ (38×10⁶–44×10⁶) per ejaculate for total sperm counts, 48% (47%–53%) for vitality, 39% (36%–43%) for total motility, 25% (23%–27%) for sperm progressive motility, 5.0% (4%–5%) for normal morphology. The pH values ranged from 7.2 to 8.0 with the mean ± standard deviation at 7.32 ± 0.17. No effects of age and body mass index were found on semen parameters. Occupation, smoking and alcohol abuse, varicocele appeared to decrease semen quality. Sperm concentration, but not sperm morphology, is positively correlated with TTP, whereas vitality is negatively correlated with TTP. Our study provides the latest reference values for the semen parameters of Chinese fertile men in Guangdong Province, which are close to those described in the new WHO guidelines (5^th Edition).     

尿清蛋白检测性能评价及尿清蛋白/肌酐比值联合肾小球滤过率对2型糖尿病患者肾损伤的诊断价值

目的评价免疫透射比浊法检测尿清蛋白(Alb)的性能,探讨尿Alb/肌酐(Cr)比值(ACR)联合估算肾小球滤过率(e GFR)在2型糖尿病(T2DM)患者肾损伤评价中的诊断价值。方法对免疫透射比浊法检测尿Alb的精密度、正确度、分析测量范围(AMR)、检测限、参考区间进行验证,并分析其与免疫散射比浊法的相关性和偏差。选取220例T2DM住院患者,检测尿Alb、尿Cr、血Cr,计算ACR和e GFR并进行分析。结果尿Alb在11.11~298.76 mg/L范围内批内、批间不精密度均小于厂家声明的标准。正确度验证显示两种诊断系统尿Alb校准品测定结果符合验证要求;CAP室间质评物(U-A、U-B)、校准验证/线性评价物(LN20-B)结果符合CAP校准验证/线性评价误差界限所规定的标准,相对偏倚小于基于生物学变异设定质量规范中的适当允许偏倚(<16.4%)。AMR验证显示尿Alb在5.08~347.93 mg/L范围内线性良好。方法学比对显示透射比浊法与散射比浊法检测尿Alb结果相关性较好,平均绝对偏差为8.6 mg/L,平均相对偏差为14.52%,在医学决定水平处的预期偏差在可接受范围内。220例T2DM患者按照正常Alb、微量Alb、大量Alb尿分组,分别有10.9%、45.7%、66.7%的患者e GFR<60m L·min-1·1.73 m-2;在e GFR≥90 m L·min-1·1.73 m-2的患者中,15.7%有微量Alb尿,7.1%有大量Alb尿。结论免疫透射比浊法检测尿Alb的各项性能指标基本满足实验室要求,联合应用ACR和e GFR有助于评估T2DM患者肾脏损伤状况。     

165例男性不育染色体核型及AZF基因缺失分析

目的探讨男性不育患者染色体核型异常及无精症因子（AZF）基因缺失与男性不育的关系。方法对2012年5月-2014年5月来本院就诊的（重庆地区）原发性男性不育患者165例,进行外周血G显带核型分析并采用多重PCR对无精症因子区域的15个标签序列位点进行检测。结果165例生精障碍患者中染色体异常共检出5例,1例为男性性反转（46,XX）,1例为克氏综合征（47,XXY）,1例为47,XY,＋mar,1例为46,XY,Y≥18,1例46,XY,in（9）,其余均为正常核型,总异常率为3.03％（5／165）;AZF基因位点发生微缺失患者共检出25例,总缺失率为15.15S。结论染色体异常和AZF微缺失是男性不育的重要原因,对男性不育诊断时有必要进行检查。     

深圳市罗湖区医改政策分析

区级医改是中国医药卫生体制改革中重要但却经常被忽视的改革环节。2015年以来,深圳市罗湖区依据国家政策导向,结合辖区内的医疗卫生需求与问题,以推进"罗湖医院集团"建设为基本策略,进行了一系列富有成效的改革措施。罗湖区的改革在有利的政策时机和外部条件下,区级政府部门探索创新,走出了一条具有特色的区级医改之路,也体现了区级政府完全可能也应该成为中国地方医改中的一个积极的行动主体。当然,罗湖医改仍在继续,很多改革效果仍待观察,但其改革经验对于其他城市的医改具有重要借鉴意义。